HAVCR2 and neoplasm: In vivo experiments confirmed that PD-L1 also reduced the antitumor effect of RIN1, including increased tumor growth (Fig. 6j) and upregulated PD-1/TIM3 expression on CD8+ T cells (Fig. 6k, Supplementary Fig. 11e).